Pharmaceuticals News

Montrouge, France, le 19 avril (23 :30 CET) 2023 DBV Technologies présente une voie réglementaire pour Viaskin Peanut chez les enfants de 1 à 3 ans après avoir reçu des réponses pré-BLA de la FDA : ...

Alvotech (NASDAQ: ALVO) tilkynnti í dag breytingar á skipulagi gæðastjórnunar Alvotech. Sandra Casaca hefur verið skipuð framkvæmdastjóri gæðamála. Sarah Tanksley tekur sæti í stjórn Alvotech hf.,...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced changes to the company’s Quality...

REYKJAVIK, Iceland, April 19, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...

Montrouge, France, April 19, 2023 DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses from FDA The FDA confirmed that the Company’s...

SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact...

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse) le 19 avril 2023 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique de stade clinique avancé engagée dans...

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 19, 2023 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the...

PALM BEACH GARDENS, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...

REDWOOD CITY, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a pre-conference workshop highlighting the...